IL-6 is not only expressed and secreted by breast cancer cells, but also by diverse cell types that are part of the tumor microenvironment, such as myeloid-derived suppressor cells (MDSCs) [53], fibroblasts [38,47], lymphatic endothelial cells [54], and adipocytes [55] (Figure 1A). This evidence concerns the gene IL6 and breast carcinoma.